drug
ansuvimab
Marketedupdated 3mo agoby Ridgeback Biotherapeutics LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(5)
approval · 5
Dec 21, 2020
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 7, 2021
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
May 19, 2022
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Dec 26, 2024
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Feb 18, 2026
approval
EBANGA (ANSUVIMAB-ZYKL) — FDA approval
ansuvimab
→
Trials studying ansuvimab
News(1)
- Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuringTwo and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”fiercebiotech · 9d ago
Data sources
last refreshed 34m ago
Found something off?
comments(0)
5-min edit window · permanent after that